Insider filing · BSX
Michael F Mahoney
Director
profile →
Boston Scientific Corporation
BSX · Healthcare · 83 filings in 24 months
ticker →
Michael F Mahoney sold $16.4M of Boston Scientific (BSX)
Executed Apr 1 2025, disclosed Apr 2 2025, 1 day later.
Value, as filed
$16.4M
164,442 sh × $100.01
Executed
Apr 1 2025
the trade date, as filed
Disclosed
Apr 2 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MMMichael F Mahoney (Director) filed 2 Form 4 reports in the trailing twelve months (1 purchase, 1 sale), most often in Boston Scientific Corporation (BSX). Across 1 priced purchase filing, the average 21-session return was +1.0% from execution and -2.2% from disclosure (delay-adjusted; derived). The largest single filing was $15.0M of BSX (160,901 sh across 2 lots, as filed), executed Feb 2.
The name
BSXHealthcare · Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties wor…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Michael F Mahoney in BSX
BSXPURCHASE
Boston Scientific Corporation
$9.0M186,240 sh × $48.33
Exec Aug 3
Filed Aug 5 · 4:15 PM ET BSXSALE Boston Scientific Corporation $15.0M
160,901 sh across 2 lots
Exec Feb 2
Filed Feb 3 · 5:30 PM ET BSXSALE Boston Scientific Corporation $17.1M
164,443 sh across 2 lots
Exec Jun 2 2025
Filed Jun 3 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation $16.9M
164,443 sh across 2 lots
Exec May 1 2025
Filed May 5 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation $13.8M
162,778 sh across 2 lots
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET BSXSALE Boston Scientific Corporation $13.8M
162,777 sh across 2 lots
Exec Oct 7 2024
Filed Oct 8 2024 · 5:30 PM ET